news Archives - Page 10 of 100 - Journal for Clinical Studies

Current Edition

news

Merck and AZ pile on more positive Lynparza data in bid to break into prostate cancer

Lynparza beat analysts' expectations in the second quarter with $283 million in sales. (AstraZeneca) Two months back, AstraZeneca and Merck made a strong case at...

8 August 2019 news | North America

Continue Reading →

news

Roche trial win for Tecentriq leaves questions unanswered

(Credit: Roche ) Roche on Monday said its immunotherapy Tecentriq helped stave off tumor growth in a Phase 3 study of previously untreated people with metastatic...

8 August 2019 news | North America | Regional News

Continue Reading →

news

Regulators, Gilead at odds over HIV drug’s use in women

(Credit: Wikimedia Commons ) Food and Drug Administration staff appear confident an HIV treatment developed by Gilead can also help prevent the disease from spre...

8 August 2019 news | North America | Regional News

Continue Reading →

news

FDA approves first therapy for rare joint tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial gi...

8 August 2019 news | North America | Regional News

Continue Reading →

Europe

Experts Predict Chat Bots and Virtualisation as On-Trend

Employee Benefits Swing Towards Individual Well Being - Summer 2019 HSC, the critical illness support specialists, have launched a new trends report for Summer 201...

6 August 2019 Europe | news | Regional News

Continue Reading →

Europe

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement

Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") announced today the three companies have entered into a clinical collaborat...

1 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Novartis’ Kisqali sharpens survival edge with second ph3 win

Novartis will unveil details from Kisqali's latest phase 3 win at an upcoming medical meeting. (Novartis) In June, Novartis’ Kisqali showed it could prolong the ...

1 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Chasing Pfizer and J&J, Bayer’s Nubeqa nabs fast FDA nod in prostate cancer

Eyeing Xtandi and Erleada, Bayer and Orion's Nubeqa has won FDA approval in non-metastatic castration-resistant prostate cancer market. (Bayer) Pfizer and Astell...

1 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

J&J advances MS drug candidate toward US, EU markets

An experimental drug developed by Johnson & Johnson for multiple sclerosis succeeded in a head-to-head study against Sanofi's on-market therapy Aubagio, accor...

1 August 2019 Europe | news | North America | Regional News

Continue Reading →

news

Novartis heart drug misses on potentially billion-dollar market

(Credit: Novartis ) After five years of testing, Novartis said Monday its heart medication Entresto "narrowly" failed a study that could have added a valuable in...

1 August 2019 news | North America | Regional News

Continue Reading →